Listed

Integra Lifesciences Holdings Corp: Form 10-Q for the period ended Jun 30, 2025

Filed with the SEC on Jul 31, 2025 and accepted by EDGAR at Jul 31, 2025, 16:02 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2025-04-01 to 2025-06-30$415.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2025-01-01 to 2025-06-30$798.3mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2025-04-01 to 2025-06-30$206.3mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2025-01-01 to 2025-06-30$394.5mus-gaap:CostOfGoodsAndServicesSold
Selling, general and administrative3 months2025-04-01 to 2025-06-30$179.9mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2025-01-01 to 2025-06-30$361.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2025-04-01 to 2025-06-30−$512.7mus-gaap:OperatingIncomeLoss
Operating income6 months2025-01-01 to 2025-06-30−$528.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2025-04-01 to 2025-06-30$21.0mus-gaap:InterestExpenseNonoperating
Interest expense6 months2025-01-01 to 2025-06-30$39.9mus-gaap:InterestExpenseNonoperating
Income tax3 months2025-04-01 to 2025-06-30−$46.9mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2025-01-01 to 2025-06-30−$51.6mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2025-04-01 to 2025-06-30−$484.1mus-gaap:NetIncomeLoss
Net income6 months2025-01-01 to 2025-06-30−$509.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2025-04-01 to 2025-06-30−$6.31us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2025-01-01 to 2025-06-30−$6.65us-gaap:EarningsPerShareDiluted
Basic EPS3 months2025-04-01 to 2025-06-30−$6.31us-gaap:EarningsPerShareBasic
Basic EPS6 months2025-01-01 to 2025-06-30−$6.65us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2025-04-01 to 2025-06-3076,695,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2025-01-01 to 2025-06-3076,579,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2025-01-01 to 2025-06-30−$2.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2025-01-01 to 2025-06-30$49.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2025-01-01 to 2025-06-30$221.0kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2025-06-30$217.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2025-06-30$1.14bnus-gaap:AssetsCurrent
Total assetsAt period end2025-06-30$3.67bnus-gaap:Assets
Current liabilitiesAt period end2025-06-30$929.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2025-06-30$2.63bnus-gaap:Liabilities
Long-term debtAt period end2025-06-30$745.9mus-gaap:LongTermDebt
Shareholders' equityAt period end2025-06-30$1.04bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000917520-25-000074. Last ingested by Listed: Nov 11, 2026, 00:10 ET. Listed shows no prices and gives no investment advice.